Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000464625 | SCV000556549 | benign | Tuberous sclerosis 2 | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313198 | SCV000847878 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000464625 | SCV002039480 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496802 | SCV002805217 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2021-09-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002069 | SCV004826782 | likely benign | Tuberous sclerosis syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing |